Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 38 (3), 319-333
- https://doi.org/10.1016/0090-6980(89)90136-6
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Reduction by prostacyclin of acetaminophen-induced liver toxicity in the mouseHepatology, 1988
- Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shockEuropean Journal of Pharmacology, 1987
- Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factorEuropean Journal of Pharmacology, 1986
- In vivo inhibition of plasma protein leakage andSalmonella enteritidis—induced mortality in the rat by a specific paf-acether antagonist: BN 52021Inflammation Research, 1986
- Potent ulcerogenic actions of platelet-activating factor on the stomachNature, 1986
- Hydrocortisone and ‘macrocortin’ inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytesLife Sciences, 1985
- Is platelet activating factor (PAF) a mediator of endotoxin shock?European Journal of Pharmacology, 1985
- Protective Effects of trans-13-APT, a Thromboxane Receptor Antagonist, in EndotoxemiaJournal of Cardiovascular Pharmacology, 1985
- Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophilsBiochemical and Biophysical Research Communications, 1984
- Elevated Thromboxane Levels in the Rat during Endotoxic ShockJournal of Clinical Investigation, 1980